Empowering Industries Nationwide with Cutting-Edge Healthcare Intelligence
Guidepoint Qsight is a leading research enablement platform designed to advance understanding and empower our clients’ decision-making processes. Powered by innovative technology, real-time data, and hard-to-source expertise, we help our clients turn answers into action.
Backed by a network of nearly 1.625 million experts and Guidepoint’s 1,300 employees worldwide, we inform leading organizations’ research by delivering on-demand intelligence and research on request. Focused exclusively on the healthcare space, our dedicated team of experienced clinicians, data scientists, and domain specialists works to reveal usage and purchasing patterns in the industry’s most dynamic markets. Qsight guides clients in extracting critical insights from the data, delivering a comprehensive product-level understanding of the market, and facilitating analysis for absolute clarity.
The Qsight Story
Beginning with Guidepoint’s acquisition of Quanton Data in 2016, Guidepoint Qsight has been a leader in advanced healthcare market intelligence.
Given the influx of alternative data in the marketplace, it’s often challenging to know what data brings value and what data is simply noise. Grounded in a wealth of proprietary data, Guidepoint Qsight’s purpose is to provide an unprecedented window into patient demands, competitive landscapes, and emerging business trends, enabling a harmonized integration of both quantitative and qualitative data into strategic planning.
Managing Director of Guidepoint’s Data Insights Team
Meet Our Team
Delivering More Than Just Data
Request a Demo Today
At Guidepoint Qsight, we empower decisions through unmatched, data-driven insights for the Aesthetics and MedTech industries. Send us your contact information today, and we’ll be in touch to discuss your concerns and overall needs. When it comes to data analytics, we’re the experts you can count on.
Our Newest Product Unleashed: Qsight Prospector
The competition between energy-based devices (EBD) and dermal fillers is intensifying in the U.S. Aesthetics market. Recent data from Qsight Market View reveals that EBD procedures are closing in on the spending dominance traditionally held by dermal fillers.
‘Tis the Season: Aesthetics Holiday Trends
With the end of year quickly approaching, the Aesthetics team at Guidepoint Qsight reviewed several years of trending data from Qsight Aesthetics Point-of-Sale and Qsight Aesthetics Tracker to unpack how behavior changes at MedSpas and Aesthetics practices in and around the holiday season.
Lightning Strikes the Peripheral Thrombectomy Market: Examining the Rise of Penumbra and the Impact of Innovative Devices
The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products.
Rapid Ascend: Axonics Gains Ground in the SNM Market Amid F15 Launch and Next-Gen R20 System Arrival
Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.